Cassava Sciencesの空売り状況は、投資家がCassava Sciencesの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Cassava Sciences (NASDAQ:SAVA) 株価情報, 空売り情報

Cassava Sciences

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Cassava Sciences Inc

Cassava Sciences Inc Warrants (15/11/2024)

SAVANNAH GOLDFIELDS LTD by SAVANNAH GOLDFIELDS LTD

Savannah Energy PLC

SAVANNAH RESOURCES PLC by SAVANNAH RESOURCES PLC

Savannah Resources PLC

Savara Inc

Savaria Corp

B. Riley Securities analyst Josh Nichols maintains Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) with a Buy and raises the price target from $14.5 to $15.5.

News

Price Target

Analyst Ratings

OOMA

B. Riley Securities Maintains Buy on Ooma, Raises Price Target to $15.5

Rumors

Trading Ideas

CRNT

Watching Ceragon Networks; Traders Circulate Stock Picked In Louis G. Navellier's Newsletter

Kohl&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) shares are trading higher by 5.6% to $17.99 Monday morning. The company is set to report third-quarter results Tuesday <a href="https://www.benzinga.com/quote/JWN/earnings">before the market open</a>.
What Happened: Kohl's heads into its third-quarter earnings release with a focus on improving operational efficiency and navigating continued sales pressure. In the second quarter, <a href="https://www.benzinga.com/news/earnings/24/08/40599429/kohls-q2-earnings-profit-beat-inventory-decline-margin-growth-and-more">net sales declined by 4.2% year-over-year</a> to $3.525 billion, with comparable sales down 5.1%. 
Despite these challenges, the company exceeded EPS expectations, reporting 59 cents versus the 44 cent consensus, supported by a 59-basis-point expansion in gross margin to 39.6%.
Operational improvements were evident as SG&amp;A expenses declined 4.2% year-over-year, contributing to a 26-basis-point increase in operating margin to 4.4%. Inventory management was a highlight, with a 9% year-over-year reduction in inventory, aligning with the company's efficiency goals.
<a href="https://www.benzinga.com/news/global/24/11/42156160/palantir-price-target-raised-to-75-by-dan-ives-amid-288-ytd-surge-analyst-calls-2025-a-primetime-year-for-ai">Read Also: Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge</a>
For Q3, attention will likely focus on Kohl's ability to stabilize sales amidst macroeconomic headwinds and discretionary spending pressures, which impacted second-quarter performance. 
Key growth areas, including the Sephora partnership and categories like home decor and gifting, will be critical drivers. The recent partnership with Babies "R" Us may also begin contributing incremental gains.
Kohl's raised its FY24 EPS outlook to $1.75–$2.25, reflecting confidence in margin expansion, despite revised guidance for FY24 sales and comparable sales declines of 4–6% and 3–5%, respectively. Investors will look for evidence in third-quarter results that Kohl's is successfully executing its strategies to balance cost controls with growth investments.
Read Also: <a href="https://www.benzinga.com/general/biotech/24/11/42164927/cassava-sciences-controversial-alzheimers-drug-fails-to-hit-primary-goal-in-pivotal-study-halts-late-stage-studies">Cassava Sciences Alzheimer&#8217;s Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies</a>
<h2 class="wp-block-heading">How To Buy KSS Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Kohl&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KSS has a 52-week high of $29.60 and a 52-week low of $16.12.

What's Going On With Kohl's (KSS) Stock?

WIIM

KODK

Eastman Kodak shares are trading higher after the company announced its income plan trust sold $764.4 million in illiquid assets to Mastercard Foundation for $550.6 million in cash.

Ethereum Classic (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/etc/usd">ETC</a>) has surged 60% to $31.17 over the past month, drawing attention in a crypto market increasingly driven by institutional interest and renewed enthusiasm for blockchain technologies. This rise aligns with a record <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42165734/bitcoin-etfs-registered-record-312-billion-net-inflows-last-week">$3.13 billion inflow</a> into digital asset investment products last week, as reported by CoinShares.
What To Know: Ethereum Classic is the original Ethereum blockchain, preserved after a contentious 2016 split following the DAO hack. While Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) adopted a new chain to reverse the effects of the hack, Ethereum Classic retained the unaltered blockchain.
ETC has carved out a niche as a decentralized smart contract platform, appealing to purists and developers who value its fixed monetary policy and proof-of-work consensus mechanism.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42161443/dogecoin-is-harder-money-than-bitcoin-says-raoul-pal-heres-what-the-numbers-say">Dogecoin Is &#8216;Harder Money&#8217; Than Bitcoin, Says Raoul Pal: Here&#8217;s What The Numbers Say</a>
Bitcoin ETFs accounted for $3.12 billion of the record inflows last week, fueling optimism across the digital asset ecosystem. Altcoins like Ethereum Classic benefited from the trickle-down effect as investors sought alternatives that offered potential for high returns.
Additionally, Ethereum Classic may be gaining traction as a proof-of-work alternative to Ethereum, which transitioned to a proof-of-stake model in 2022. ETC miners displaced by Ethereum's shift could find a home on Ethereum Classic's network, further enhancing its security and utility.
While the record inflows into Bitcoin-dominated headlines, Ethereum Classic's outsized gains highlight the growing interest in assets beyond Bitcoin and Ethereum.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42163156/why-bitcoins-rally-is-stalling-below-100000">Why Bitcoin&#8217;s Rally Is Stalling Below $100,000</a>

$ETC

$ETH

Ethereum Classic Surges 60% In A Month: What's Driving the Rally?

Guggenheim analyst John Heinbockel maintains Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Buy and raises the price target from $61 to $63.

Guggenheim Maintains Buy on Kroger, Raises Price Target to $63

POET Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POET#NASDAQ">POET</a>) shares are trading higher. The company on Monday announced plans to expand its capacity to meet <a href="https://www.benzinga.com/pressreleases/24/11/g42160002/poet-expands-capacity-to-meet-ai-infrastructure-demand">AI infrastructure demand</a>. 
What Happened: Poet announced plans to expand its optical engine production capacity in Malaysia. The company signed a binding Memorandum of Understanding with Quanzhou Sanan Optical Communication Technology (SAIC). Under the terms, SAIC will transfer to Poet its&nbsp;24.8%&nbsp;stake in the joint venture Super Photonics Xiamen, making Super Photonics a wholly owned subsidiary of Poet.
With control of Super Photonics Xiamen, Poet will gain the flexibility to implement its &#8220;China Plus One&#8221; strategy to locate its wafer-scale assembly operations outside of China.
Poet also said its been negotiating with several contract manufacturers in Malaysia to become the focal point for the company&#8217;s wafer-scale assembly of optical engines. Poet expects to sign an agreement this month and to begin operations by the end of the year. 
See Also: <a href="https://www.benzinga.com/news/global/24/11/42156160/palantir-price-target-raised-to-75-by-dan-ives-amid-288-ytd-surge-analyst-calls-2025-a-primetime-year-for-ai">Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A &#8216;Primetime&#8217; Year For AI</a>
&#8220;The addition of wafer-scale equipment to our assembly and test operations will significantly expand our production capacity to cover the projected needs of our customers for 800G optical engines being sold to AI networks through 2026,&#8221; said Suresh Venkatesan, chairman and CEO of Poet. 
&#8220;We can now project an assembly and test capacity exceeding one million optical engines per year, all dedicated to the 800G and higher speed transceivers required for AI clusters.&#8221;
Poet noted that definitive agreements related to the deal are expected to be signed by the end of November. 
POET Price Action: <a href="http://benzinga.com/quote/poet">Poet shares</a> were up 5.49% at $4.23 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Global

Movers

POET

What's Going On With POET Technologies Stock Monday?

Dollar Gen's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) short percent of float has risen 7.67% since its last report. The company recently reported that it has 6.55 million shares sold short, which is 3.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.69 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Dollar Gen Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732552221_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dollar Gen has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Dollar Gen's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Dollar Gen's peer group average for short interest as a percentage of float is 3.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Dollar Gen's Recent Short Interest

Unity Software's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) short percent of float has fallen 5.04% since its last report. The company recently reported that it has 24.40 million shares sold short, which is 6.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.33 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Unity Software Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732552215_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Unity Software has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Unity Software's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Unity Software's peer group average for short interest as a percentage of float is 6.78%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(U) - Analyzing Unity Software's Short Interest

CenterPoint Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) short percent of float has fallen 5.82% since its last report. The company recently reported that it has 18.19 million shares sold short, which is 3.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.61 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CenterPoint Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732552210_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CenterPoint Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CenterPoint Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CenterPoint Energy's peer group average for short interest as a percentage of float is 2.47%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(CNP) - Analyzing CenterPoint Energy's Short Interest

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) showcased a groundbreaking generative AI <a target="_blank" href="https://blogs.nvidia.com/blog/fugatto-gen-ai-sound-model/" rel="noreferrer noopener">model </a>named Fugatto. This model is designed as a versatile tool for creating and modifying sounds using text and audio prompts. Fugatto can generate and transform a mix of music, voices, and soundscapes, offering unprecedented capabilities to musicians, developers, and content creators.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/11/42139806/echostar-shares-sink-as-directv-terminates-acquisition-agreement" rel="noreferrer noopener">EchoStar Shares Sink As DirecTV Terminates Acquisition Agreement</a>
Fugatto, short for Foundational Generative Audio Transformer Opus 1, supports multiple tasks, such as generating new music, altering accents or emotions in voices, and crafting entirely novel soundscapes. These features mark a significant leap in audio AI innovation.
Fugatto empowers users to create audio that combines various instructions and prompts. For example, it can produce a trumpet sound mimicking a barking dog or generate a voice with a specific accent and tone.
Beyond music, Fugatto opens possibilities for advertising, education, and gaming. Advertisers can adjust campaign voiceovers for regional audiences, while educators can personalize content with voices familiar to learners. Game developers can modify audio assets or generate them dynamically based on gameplay.
Fugatto, powered by a 2.5-billion-parameter generative transformer, was trained on Nvidia DGX systems with 32 H100 Tensor Core GPUs. Its development involved a diverse team spanning several countries, which enhanced its multilingual and multi-accent capabilities. The model&#8217;s training relied on millions of audio samples, carefully curated to enable complex and diverse tasks.
Fugatto&#8217;s debut signifies a milestone in generative AI, promising to reshape how professionals interact with sound.
The model enables users to combine attributes like accent, tone, and emotion into one cohesive sound. For instance, it can create a dynamic soundscape transitioning from a thunderstorm to a tranquil dawn.
Nvidia stock surged 186% year-to-date.
Last week, Nvidia reported a <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam" rel="noreferrer noopener">third-quarter revenue</a> of $35.1 billion, up 94%, beating the consensus estimate of $33.12 billion.
The company reported EPS of 81 cents, which beat the Street consensus estimate of 75 cents. Nvidia expects fourth-quarter revenue to be $37.5 billion plus or minus 2%.
Analysts highlighted Nvidia&#8217;s leadership in AI and data center technologies, with robust demand for its Blackwell and Hopper <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42119226/nvidia-analysts-see-stock-best-positioned-in-ai-not-worried-about-guidance-all-systems-go-for-blackwell-ramp" rel="noreferrer noopener">product lines driving growth through 2025.</a>
Investors can gain exposure to Nvidia through ProShares Ultra Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USD#NYSE">USD</a>) and EA Series Trust Strive U.S. Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NYSE">SHOC</a>).
Price Action: NVDA stock is down 2.7% at $138.12 at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42137930/boeing-secures-238-billion-deal-for-advanced-kc-46a-tankers" target="_blank" rel="noreferrer noopener">Boeing Secures $2.38 Billion US Air Force Deal for Advanced KC-46A Tankers</a></li>
</ul>
Photo via Shutterstock.

Equities

Tech

General

NVDA

EA Series Trust Strive U.S. Semiconductor ETF

SHOC

Nvidia Unveils Fugatto: AI Tool That Transforms Sound Creation For Music, Ads, And Gaming

Ascendiant Capital analyst Lucas Ward maintains LiqTech Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>) with a Buy and lowers the price target from $5.15 to $3.2.

LIQT

Ascendiant Capital Maintains Buy on LiqTech Intl, Lowers Price Target to $3.2

B. Riley Securities analyst Craig Ellis maintains D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and raises the price target from $3.75 to $4.5.

QBTS

B. Riley Securities Maintains Buy on D-Wave Quantum, Raises Price Target to $4.5

POET Technologies shares are trading higher after the company announced plans to expand its capacity.

B. Riley Securities analyst Craig Ellis maintains Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) with a Buy and raises the price target from $3.5 to $4.

RGTI

B. Riley Securities Maintains Buy on Rigetti Computing, Raises Price Target to $4

Bitcoin Cash (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bch/usd">BCH</a>), a peer-to-peer digital currency designed to offer faster and cheaper transactions compared to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), has surged 40.7% to $520.08 over the past month, buoyed by historic levels of <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42165734/bitcoin-etfs-registered-record-312-billion-net-inflows-last-week">institutional investment</a> in cryptocurrency as Bitcoin nears the $100,000 level.
What To Know: According to CoinShares, digital asset investment products saw a record-breaking $3.13 billion in net inflows last week, driven primarily by Bitcoin exchange-traded funds (ETFs), which alone accounted for $3.12 billion. Year-to-date inflows now stand at $37 billion, signaling growing confidence in cryptocurrencies as a mainstream asset class.
While Bitcoin dominated these inflows with $3 billion, altcoins like Bitcoin Cash have seen renewed interest. BCH, which emerged from a 2017 Bitcoin hard fork, aims to enhance transaction speed and scalability. It benefits from its association with Bitcoin while providing utility as a decentralized payment network, gaining traction as blockchain adoption grows.
Meanwhile, short-Bitcoin products saw $10 million in inflows, reflecting mixed market sentiment as Bitcoin prices hover near all-time highs.
As institutional investments flood the space, Bitcoin Cash has capitalized on broader market enthusiasm, positioning itself as one of the favored altcoins in the digital currency ecosystem.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42163156/why-bitcoins-rally-is-stalling-below-100000">Why Bitcoin&#8217;s Rally Is Stalling Below $100,000</a>

$BCH

$BTC

Why Bitcoin Cash Is Up 40% Over The Past Month

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) with a Buy and maintains $17 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target

Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) reportedly plans to enter the mobile device market with new accelerated processing unit (APU) chips <a href="https://www.benzinga.com/topic/amd">designed for smartphones. </a>
The chips will leverage Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) 3nm process, extending Taiwan Semiconductor&#8217;s order visibility for 3nm production into late 2026, UDN.com <a href="https://udn.com/news/story/7240/8382001#goog_rewarded" target="_blank" rel="noreferrer noopener">reports</a>.
The new APU chips are rumored to target flagship smartphones, potentially being used in models from Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>).
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25075427/newplot-13.png" alt="" class="wp-image-663223" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25075427/newplot-13.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25075427/newplot-13-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41339315/nvidia-and-intel-competition-threaten-amds-growth-analyst-says" target="_blank" rel="noreferrer noopener">Nvidia and Intel Competition Threaten AMD&#8217;s Growth, Analyst Says</a>
AMD previously collaborated with Samsung on the Exynos 2200 processor, which featured a GPU based on AMD&#8217;s RDNA 2 architecture. However, this earlier partnership focused on graphic enhancements rather than central processor development.
AMD&#8217;s current MI300 series processors, known for their application in AI servers, could lay the groundwork for these upcoming mobile APUs. Industry insiders suggest that Samsung integrate these APUs into its premium devices, which rely heavily on Taiwan Semiconductor-manufactured components, such as Qualcomm Inc processors in the Galaxy S series.
According to Taiwan Semiconductor, its 3nm technology, including N3, N3E, and N3P nodes, has drawn significant interest from major clients like AMD, Apple Inc, and MediaTek. The demand for these advanced chips is so high that Taiwan Semiconductor has tripled its production capacity compared to last year. However, it still needs to work on meeting the overwhelming number of orders.
Taiwan Semiconductor&#8217;s ongoing development of its 3nm family will further address emerging needs in AI, mobile devices, and automotive computing.
AMD posted third-quarter revenue of $6.8 billion, surpassing <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41612007/amd-q3-earnings-revenue-beat-eps-in-line-data-center-up-122-significant-growth-opportunities-ahead-" rel="noreferrer noopener">analyst expectations of $6.71 billion</a>. Revenue grew 18%, driven by a 122% increase in Data Center revenue, which reached $3.5 billion. Client segment revenue rose 29% to $1.9 billion. However, Gaming revenue dropped 69% to $462 million, while Embedded revenue decreased 25% to $927 million.
For the fourth quarter, AMD projects revenue of $7.5 billion, plus or minus $300 million, reflecting 22% growth at the midpoint.
Goldman Sachs analyst&nbsp;Toshiya Hari <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41431993/amd-to-benefit-from-ai-competitive-arms-race-goldman-sachs" rel="noreferrer noopener">credited AMD&#8217;s growth</a> to increasing capital investment in AI infrastructure, driven by enterprises in an &#8220;AI arms race.&#8221; AMD&#8217;s robust product pipeline, including competitive GPUs and the integration of ZT Systems, positions the company for accelerated growth.
Rebounding demand for server CPUs and market share gains in enterprise-targeted SKUs will likely boost revenue and margins.
Price Actions: AMD stock is up 2.4% at $141.75 at the last check on Monday. TSM is down 2.6%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42158933/amazons-ai-chip-strategy-targets-nvidias-dominance-in-data-centers" target="_blank" rel="noreferrer noopener">Amazon&#8217;s AI Chip Strategy Targets Nvidia&#8217;s Dominance In Data Centers</a></li>
</ul>
Photo: Shutterstock

Media

SSNLF

AMD Teams Up With Taiwan Semi To Take On Samsung In Smartphone Market

B. Riley Securities analyst Matt Howlett maintains Abacus Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) with a Buy and raises the price target from $16 to $17.

B. Riley Securities Maintains Buy on Abacus Life, Raises Price Target to $17

Following a strong second-quarter performance, Nordstrom Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) will deliver insights into its third-quarter results Tuesday after-hours. In the second quarter, the company outperformed <a href="https://www.benzinga.com/news/earnings/24/08/40588492/nordstrom-stock-rallies-on-strong-q2-earnings-details">earnings expectations with EPS of $0.96</a>, a 35.21% beat over the consensus estimate of $0.71, driven by strategic pricing and operational efficiencies. 
What Happened: Although quarterly sales of $3.894 billion narrowly missed estimates, they represented a 3.23% year-over-year increase, with digital sales up 6.2% and notable growth in Nordstrom Rack's net sales (+8.8%).
The second quarter gross profit margin of 36.6%—a 155 basis point improvement—showcased Nordstrom's focus on full-price sales and leveraging higher volumes. However, the 8.3% increase in ending inventory relative to sales growth warrants attention as the company balances stock management in a dynamic retail landscape.
Read Also: <a href="https://www.benzinga.com/news/global/24/11/42156160/palantir-price-target-raised-to-75-by-dan-ives-amid-288-ytd-surge-analyst-calls-2025-a-primetime-year-for-ai">Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge</a>
For the third quarter, analysts will likely focus on Nordstrom's ability to sustain growth across both banners, particularly Nordstrom Rack, which demonstrated robust performance in the second quarter. 
Comparable sales, which increased 1.9% in the prior quarter, could signal continued consumer resilience amid economic pressures. Margins and inventory levels will remain key indicators of operational efficiency.
Nordstrom's FY guidance of $1.75–$2.05 per share suggests confidence in its growth trajectory. With strategic momentum and a focus on profitability, third quarter results will be a critical checkpoint as the company progresses toward its 2024 objectives.
Read Also: <a href="https://www.benzinga.com/general/biotech/24/11/42164927/cassava-sciences-controversial-alzheimers-drug-fails-to-hit-primary-goal-in-pivotal-study-halts-late-stage-studies">Cassava Sciences Alzheimer&#8217;s Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies</a>
<h2 class="wp-block-heading">Is JWN A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/JWN">Nordstrom</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/JWN">Nordstrom</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JWN has a 52-week high of $24.93 and a 52-week low of $14.65.

What's Going On With Nordstrom (JWN) Stock?

Cassava Sciences (SAVA) announced the appointment of Freda Nassif as Chief Commercial Officer, effective today. "I am thrilled to expand Cassava's ...

Cassava Sciences appoints Freda Nassif as Chief Commercial Officer

Cassava taps Freda Nassif as chief commercial officer as simufilam Phase 3 readout nears

Bearish flow noted in Cassava Sciences (SAVA) with 3,180 puts trading, or 1.8x expected. Most active are 11/22 weekly 13 puts and 11/22 weekly 25 p...

Cassava Sciences put volume heavy and directionally bearish

Cassava Sciences (SAVA) announced that the topline results from the Phase 3 ReThink-ALZ study of simufilam in mild-to-moderate AD did not meet each...

Cassava announces Phase 3 ReThink-ALZ data did not meet co-primary endpoints

Cassava plummets 86% as simufilam phase 3 Alzheimer's trial misses endpoints

Latest data shows the largest indicative borrow rate increases among liquid option names include: Nano Nuclear Energy Inc (NNE) 96.93% +11.23, Wix....

Largest borrow rate increases among liquid names

In a report released today, Soumit Roy from JonesTrading maintained a Hold rating on Cassava Sciences (SAVA – Research Report). The company's share...

JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)

D. Boral Capital keeps a Buy rating on Anavex Life Sciences (AVXL) with a $46 price target after Cassava Sciences' (SAVA) Phase 3 trial for simufil...

D. Boral says Anavex Alzheimer's approach superior to Cassava

09:04 EST Cassava Sciences (SAVA) sinks 84% to $4.21 after Alzheimer's study miss Published first on TheFly – the ultimate source for real-time, ma...

Cassava Sciences sinks 84% to $4.21 after Alzheimer's study miss

Biggest stock movers Monday: BCOV, BHVN, SAVA, ALAR, and more

ALAR

ASRT

AVXL

BBWI

BCOV

BHVN

EOSE

GALT

LTBR

NVNXF

SAVA

SGML

Earnings

Press Releases

Cassava Sciences Reports Q2 2024  Financial Results and Operational Updates

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

Management

Cassava Sciences Names Rick Barry as Chief Executive Officer

Health Care

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

Legal

Cassava Sciences Resolves SEC Investigation

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

Cassava Sciences Reports Q3 2024 Financial and Operating Results

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

Cassava Sciences to Hold Corporate Update on November 25th

Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

ANI Pharmaceuticals

Arvinas

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences

Harrow

Indivior

Innoviva

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Liquidia

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Nuvation Bio

Ocular Therapeutix

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

Pliant Therapeutics

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Tarsus Pharmaceuticals

Tilray Brands

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

HC Wainwright & Co.

Rodman & Renshaw

B. Riley Securities

Cassava Sciences  shares are trading lower after the company announced Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study.

Comments

Cassava Sciences

空売り

Cassava Sciences (NASDAQ:SAVA) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル